ephrin-A (EFNA) Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin is a small molecule compound that has been investigated for its potential to inhibit ephrin/ephrin receptor interactions. | ||||||
NVP-BHG712 | 940310-85-0 | sc-364554 sc-364554A | 5 mg 50 mg | $232.00 $1764.00 | ||
NVP-BHG712 is a selective inhibitor of EphB4, which may indirectly affect ephrin signaling through crosstalk between EphB and ephrin-A receptors. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a tyrosine kinase inhibitor that has been studied for its ability to inhibit ephrin signaling by targeting kinases downstream of Eph receptors. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib, another tyrosine kinase inhibitor, has shown some inhibitory effects on ephrin-induced signaling pathways. | ||||||
SR 8278 | 1254944-66-5 | sc-473353 | 10 mg | $344.00 | ||
SR-8278 is a small molecule inhibitor that targets ephrin and ephrin-B1 interactions, interfering with downstream signaling pathways. | ||||||